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CCL = CC chemokine ligand; CXCL = CXC chemokine ligand; HLA = human leukocyte antigen; IFN = interferon; IL = interleukin; LT = lympho-
toxin; RA = rheumatoid arthritis; TNF = tumour necrosis factor.
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Abstract
In rheumatoid arthritis, T cells, B cells, macrophages, and dendritic
cells invade the synovial membranes, establishing complex micro-
structures that promote inflammatory/tissue destructive lesions. B
cell involvement has been considered to be limited to autoantibody
production. However, recent studies suggest that B cells support
rheumatoid disease through other mechanisms. A critical element
of rheumatoid synovitis is the process of ectopic lymphoid neo-
genesis, with highly efficient lymphoid architectures established in
a nonlymphoid tissue site. Rheumatoid synovitis recapitulates the
pathways of lymph node formation, and B cells play a key role in
this process. Furthermore, studies of rheumatoid lesions implanted
in immunodeficient mice suggest that T cell activation in synovitis is
B cell dependent, indicating the role played by B cells in
presenting antigens and providing survival signals.
Introduction
The role played by B cells in the pathogenesis of rheumatoid
arthritis (RA) has recently come back into focus. The discovery
of B cell generated autoantibodies in patients with RA
provided the first clue that the disease is immune mediated.
This original observation drove therapeutic approaches to RA
and generated intense interest in how B cells influence the
disease process. By the late 1960s it was clear that other
factors play a major role, and since 1980 treatment strategies
have focused on the effector mechanisms of macrophages
and the cytokines that are produced during inflammatory
responses. The recent success of B cell depletion therapy
using rituximab [1] – a chimeric mouse/human monoclonal
antibody directed against CD20 – has led researchers and
clinicians to re-examine the role played by B cells in the
etiology of RA.
Activation of CD4+ T cells by synovial B cells
CD20+ B cells, a prominent population in rheumatoid synovial
tissue, are present in the majority of RA patients. Immuno-
histochemical analysis reveals that they can acquire a very
distinct follicular organization, which is reminiscent of the
functional unit of secondary lymphoid tissues, the germinal
centers. The organization of B cells in ectopic germinal
centers [2] raises interesting questions about their role in
promoting rheumatoid disease. Is their only contribution the
production of autoantibodies, or do they participate in other
mechanisms that lead to synovial inflammation?
Takemura and coworkers [3] addressed this question by
depleting B cells from the rheumatoid synovium. Severe
combined immunodeficient mice were engrafted with synovial
tissue taken from RA patients, allowing for subsequent
explantation and analysis of morphology, cytokine production,
and function of germinal centers. The contribution of
engrafted B cells to inflammatory processes in these mice
was assessed using antibody mediated cell depletion. A 3-
day course of anti-CD20 antibodies caused total dissociation
of B cell follicular structures, as well as dramatic reductions in
the levels of IL-1β and IFN-γ, suggesting that B cells affect
the function of the T cells and macrophages that generate
these proinflammatory cytokines.
Takemura and coworkers [3] also examined the role played by
CD4+ T cells in inflammatory processes in engrafted synovium
by isolating T cell clones from microdissected synovial follicles.
These clones were adoptively transferred by tail vein injection
into mice engrafted with autologous synovial tissue. Monitoring
of cytokine production in the engrafted synovium revealed that
transfer of T cell clones caused a threefold to fourfold increase
in IFN-γ transcripts, and a twofold to threefold increase in the
abundance of IL-1β and tumor necrosis factor (TNF)-α
transcripts. Notably, transfer of T cell clones isolated from
peripheral blood did not stimulate cytokine production. This
selective activation of tissue-derived T cells is most consistent
with the model in which these cells recognize a local antigen,
and suggests that they drive the inflammatory response by
producing IFN-γ and regulating the function of macrophages
and synoviocytes that are the source of IL-1β and TNF-α.
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To determine whether the activation of CD4+ T cells in these
experiments was restricted by human leukocyte antigen (HLA)
class II molecules, T cell clones were transferred to mice
engrafted with HLA-DRB1 mismatched synovium. All T cell
clones that were shown to function in autologous tissue also
had proinflammatory activity in heterologous tissue that shared
one common HLA-DRB1 allele. Thus, all components required
to trigger the activity of the CD4+ T cell clones are present in
heterologous synovial tissue, and antigens driving
inflammation are shared by different patients. However,
adoptive transfer of T cells to mice carrying tissue mismatched
for both alleles did not stimulate cytokine production,
documenting the need for HLA-restricted recognition events.
Finally, in order to assess directly the role played by B cells in
CD4+ T cell activation, Takemura and coworkers [3] engrafted
mice with rheumatoid synovial tissue containing few or no B
cells. Such experiments were possible because not all
patients form germinal centers in synovial infiltrates. Rather,
heterogeneity exists in the organization and the composition of
tissue invading T cells and B cells. In some patients, B cells
are absent from the synovial lesions. Alternatively, B-cell free
synovial tissues can be generated by using depleting anti-
CD20 antibody. Adoptive transfer of HLA-DRB1-matched
T cell clones into mice engrafted with synovial tissue lacking
B cells failed to stimulate cytokine production, indicating that
B cells are critical in supporting in situ activation of T cells and
in maintaining the continuous production of proinflammatory
cytokines by macrophages and synoviocytes.
B cells and ectopic lymphoid organogenesis
The data reported by Takemura and coworkers [3] suggest
that B cells are absolutely required to support the activation
and effector function of synovial CD4+ T cells, extending their
functional contribution to the disease process far beyond
autoantibody production [4]. The nature of this supportive
interaction is as yet unclear, although two possibilities seem
likely: B cells present antigens to autoreactive T cells, driving
their activation; or the presence of B cells in synovial tissue
generates survival signals for T cells.
In order to appreciate how B cells function in rheumatoid
synovitis, it is important to understand their role in the
histological architecture of synovial lesions. The joints of
some RA patients exhibit what appear to be functional
ectopic germinal centers (Fig. 1a), with T cells and B cells
arranged around a network of dendritic cells. Lesions in other
patients do not form follicular microstructures, but rather
contain aggregates of T cells and B cells (Fig. 1b), whereas
still other lesions have a diffuse arrangement of T cells and B
cells (Fig. 1c). These patterns of synovial histology are stable
over time and consistent within patients, with tissues from
distinct joints exhibiting the same type of inflammatory lesion.
Interestingly, these patterns can be correlated with bio-
markers for B cell activity. The relationship between B cells
and the establishment of complex lymphoid architectures has
been studied in a large cohort of synovial biopsies, all
collected from patients with active rheumatoid synovitis
(authors’ unpublished data). As a first step, B cell activity in
the tissues was determined by quantifying immunoglobulin
transcription. Interestingly, rheumatoid synovium can display a
wide range of IgG production, varying over several orders of
magnitude. Tissues containing germinal centers tend to have
the highest levels of IgG mRNA, tissues containing B cell
aggregates have intermediate levels, and tissues with a
diffuse arrangement of T cells and B cells tend to have the
lowest levels.
Clearly, the functional significance of these patterns makes it
critical to understand how lymphoid organogenesis occurs in
synovial tissue. Organization of cells in lymphoid organs and
in inflammatory lesions is orchestrated by chemokines –
soluble messengers that stimulate chemotactic behavior. Two
such molecules, namely CC chemokine ligand (CCL)2 and
CCL18, were previously proposed to play a role in
recruitment of lymphocytes and macrophages to rheumatoid
lesions. Analysis of the levels of these molecules in synovial
tissue, however, reveals no significant correlation between
patterns of B cell organization and levels of CCL2 or CCL18
mRNA production, suggesting that other chemokines are
Figure 1
B cells in rheumatoid synovium. Tissue biopsies were collected from patients with active synovitis. Infiltrates of B cells and T cells are often
arranged in complex microarchitectures. Three patterns can be distinguished. (a) T cells and B cells can form typical germinal centers. 
(b) Alternatively, they can be clustered in aggregates that lack follicular dendritic cells and have no germinal center reaction. (c) The third pattern is
formed by T cells and B cells infiltrating diffusely into the synovial stroma. Reproduced with permission [7].S11
more important in directing how B cells are recruited to the
synovial membrane and determining how they arrive at a
distinct site in the synovial microenvironment.
Indeed, analysis of other chemokines reveals an intriguing
relationship between lesion architecture and chemokine
levels. Takemura and coworkers [5] found that two
chemokines, namely CXC chemokine ligand (CXCL)13 and
CCL21, are major determinants of germinal center formation.
CXCL13 has been implicated in the recruitment of B cells,
whereas CCL21 has been shown to attract T cells. Again,
both of these chemokines are found at high levels in synovial
tissues that are capable of forming germinal centers and at
low levels in other rheumatoid lesions (Fig. 2b,c). Thus,
CXCL13 and CCL21 are not only involved in regulating the
positioning of T cells and B cells in structured lymphoid
organs; they also serve a critical role in supporting the
infrastructure of the rheumatoid lesion. The end result is a
process of ectopic lymphoid neogenesis, providing the
disease lesion with robust structural support. It is important to
recognize that this process is directly related to the
functioning of B cells and relies on their contributions far
beyond the release of autoantibodies.
Takemura and coworkers [5] provided a clue to the process
by which B cells may regulate ectopic germinal center
formation. They observed that two members of the TNF
superfamily, lymphotoxin (LT)-α and LT-β, were differentially
expressed in tissues with distinct B cell organization. These
proteins form α1β2 heterotrimers and, along with CXLC13
and CCL21, have been implicated in lymph node formation in
mouse knockout models. There is now evidence that in
rheumatoid synovitis LT-β is supplied by B cells. Analysis of
LT-β mRNA production in synovial tissue reveals a strong
correlation with levels of IgG production, two markers closely
related to synovial architecture (Fig. 2a). The relationship
between LT-β production and IgG production was the first
hint that B cells are the cellular source of the TNF-like ligand.
Indeed, immunohistochemical analysis has identified
expression of LT-β on a subset of B cells. Specifically, LT-β+
B lymphocytes are positioned in the follicular mantle zone,
assigning a critical contribution of that structure to ectopic
lymphoid organogenesis.
Braun and coworkers [6] demonstrated recently that LT-α1β2
has functions beyond regulating how B cells are embedded
into a three-dimensional network. LT-α1β2 stimulation also
causes profound changes in the function of synovial
fibroblasts. In particular, LT-α1β2 stimulation led to the
induction of a number of factors in fibroblast-like synoviocytes
that contribute to inflammation and T cell recruitment. These
include IL-1β; matrix metalloproteinases; the T cell attracting
chemokines CCL2, CCL5, and CCL8; and cell adhesion
molecules required for efficient attachment of lymphocytes.
These data support a critical role for LT-β producing B cells
in sustaining principal disease pathways in rheumatoid
synovitis. Such disease pathways include the process of
lymphoid organogenesis as well as sustaining the activation
of tissue resident fibroblasts.
Conclusion
It is now clear that B cells play multiple roles in the
rheumatoid disease process. In addition to their classical role
as producers of autoantibodies, B cells are central to the
activation of CD4+ T cells in synovial tissue, and depletion of
B cells disrupts the production of proinflammatory cytokines
by T cells and macrophages. B cells have also been
implicated in the process of ectopic lymphoid organogenesis.
In normal secondary lymphoid tissue, germinal center
formation requires the expression of numerous cytokines and
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Figure 2
B cells support ectopic lymphoid organogenesis in rheumatoid synovitis. cDNA was generated from synovial biopsies of patients with rheumatoid
arthritis, and production of CXC chemokine ligand (CXCL)13, CC chemokine ligand (CCL)21, and lymphotoxin (LT)-β mRNA was quantified by
real-time polymerase chain reaction. Tissues were categorized as having germinal centers (GCs), aggregates, or diffuse infiltrates as described in
Fig. 1. Results are shown as box plots with medians, 25th and 75th percentiles as boxes, and 10th and 90th percentiles as whiskers. (a) Tissues
with GCs produced significantly higher levels of the tumor necrosis factor-like ligand LT-β – a molecule that is involved in lymphoid organogenesis.
(b) These tissues also expressed the highest concentrations of the B cell recruiting chemokine CXCL13. (c) Similar to lymph nodes, GC-forming
synovial tissues contained high levels of the T-cell attracting chemokine CCL21. Reproduced with permission [5]. Copyright 2001, The American
Association of Immunologists, Inc.S12
chemokines. The observation that synovial follicular structures
express high levels of several of these molecules suggests
that rheumatoid synovitis utilizes similar building blocks and
construction principles as lymph nodes. The end results are
highly effective and complex three-dimensional arrangements
of lymphocytes and fibroblasts that provide ideal conditions
for continuous immune stimulation. B lymphocytes supply LT-
β, a key factor in ectopic lymphoid neogenesis, and thus hold
a central position in shaping the synovial microenvironment
and turning it into a disease permissive site.
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